US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Dimensional World ex U.S. Core Equity 2 ETF
(NY:
DFAX
)
37.28
+0.46 (+1.25%)
Official Closing Price
Updated: 8:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dimensional World ex U.S. Core Equity 2 ETF
< Previous
1
2
3
Next >
Shell Stock Hits 52-Week High – Here’s Why
↗
March 09, 2026
Rise in oil prices amid the ongoing conflict in the middle-east has spiked Brent crude and other energy product prices.
Via
Stocktwits
TrueWealth Financial Buys $12 Million of First Trust Managed Municipal ETF
↗
February 19, 2026
This municipal bond ETF delivers tax-exempt income through a diversified portfolio of federally tax-free debt securities.
Via
The Motley Fool
Topics
Bonds
ETFs
Regulatory Compliance
LRI Investments Buys $16 Million of Vanguard 0-3 Month Treasury Bill ETF
↗
February 17, 2026
This ETF tracks short-term U.S. Treasury bills, offering investors a liquid, low-risk vehicle for short-duration capital allocation.
Via
The Motley Fool
Topics
ETFs
Regulatory Compliance
Novo Nordisk In Green After Oral Wegovy Clocks Over 18K Prescriptions In A Week
↗
January 23, 2026
Via
Stocktwits
BHC Stock Plummets On Failed Liver Cirrhosis Trial: Retail Says ‘Lost Battle But Not The War’
↗
January 23, 2026
Via
Stocktwits
Stellantis Stock Drops As It Reportedly Scraps Jeep and Chrysler Plug-In Hybrid Vehicles In US
↗
January 09, 2026
Via
Stocktwits
Tilray Stock On Track For Near 2-Month High As 'Weednesday' Buzz Builds Around Trump Cannabis Order — Retail Eyes Massive Upside
↗
December 16, 2025
Via
Stocktwits
Topics
Cannabis
Government
Novo Nordisk To Launch Ozempic Pills Following Flat Growth In Diabetes Segment In 2025
↗
February 04, 2026
The Ozempic pill will be launched in Q2 2026 and be available in doses 1.5 mg, 4 mg, and 9 mg.
Via
Stocktwits
Novo Nordisk Shares Tumble On Q4 Miss, Weak Sales Forecast And Competition Concerns
↗
February 03, 2026
The drugmaker now expects fiscal 2026 adjusted sales down 5% to 13%.
Via
Stocktwits
Why Bitfarms Stock Is Down After Hours?
↗
January 26, 2026
Keefe Bruyette downgraded Bitfarms to ‘Market Perform’ from ‘Outperform’.
Via
Stocktwits
Topics
Artificial Intelligence
Novo Nordisk Inks Deal With Canada’s Aspect Biosystems To Find More Diabetes Meds Besides Ozempic
↗
January 20, 2026
Novo and Aspect have been collaborating since 2023 to develop cellular medicines, and said that the new partnership phase builds on the momentum achieved in the existing collaboration.
Via
Stocktwits
NVS Stock Rises After FDA Grants Breakthrough Therapy Designation For Autoimmune Disorder Treatment
↗
January 16, 2026
Novartis looks to submit data from its many trials of Ianalumab with health authorities starting in early 2026 for potential approval.
Via
Stocktwits
Novo Nordisk’s Experimental GLP-1 Drug Shows Weight Loss, Blood Sugar Levels Reduction In Study
↗
November 25, 2025
Via
Stocktwits
BABA Stock Rises Pre-Market As AI-Driven Cloud Growth Drives Revenue Beat
↗
November 25, 2025
Via
Stocktwits
Stellantis CEO Says New Engine, Vehicle Models Will Drive ‘Progressively Better’ Demand
↗
December 04, 2025
Filosa said that the company is on track on its full year guidance through the end of November.
Via
Stocktwits
Topics
Government
World Trade
Li Auto Posts Unexpected Loss In Q3 As EV Sales Drop
↗
November 26, 2025
CEO Xiang Li highlighted challenges pertaining to the supply chain and product lifecycle, among others.
Via
Stocktwits
Topics
Economy
Novo Nordisk’s Blockbuster Drug Fails To Slow Alzheimer’s Disease Progression In Studies
↗
November 24, 2025
The company said that it is discontinuing the trials.
Via
Stocktwits
Novo’s Obesity Drug Patients Granted Compensation In Denmark Over Rare Eye Disease Linked To Wegovy, Ozempic
↗
November 21, 2025
Via
Stocktwits
Takeda Pharmaceuticals’ Genetic Disease Therapy Under FDA Probe After Pediatric Patient Dies
↗
November 21, 2025
The death of a pediatric congenital thrombotic thrombocytopenic purpura patient appears to be related to Adzynma, the FDA said.
Via
Stocktwits
Toyota Commits Up To $10B Additional Investments In US Over Five Years
↗
November 12, 2025
Via
Stocktwits
Novartis Opens New Manufacturing Facility In California In Bid To Increase US Presence
↗
November 10, 2025
Via
Stocktwits
AstraZeneca Announces $4.5B Investment In Virginia
↗
October 09, 2025
Via
Stocktwits
AstraZeneca Plans Ordinary Share Listing In US – Find Out More On The Harmonized Listing Structure
↗
September 29, 2025
Via
Stocktwits
Novo Nordisk Brings Back Former CEO To Lead Board
↗
November 14, 2025
Meanwhile, Cees de Jong was elected vice chair, replacing Henrik Poulsen, while Britt Meelby Jensen and Stephan Engels were appointed as members of the board at the meeting on Friday.
Via
Stocktwits
Stellantis NV Recalls Over 320,000 Jeep Plug-In Hybrids In US Over Fire Risk
↗
November 04, 2025
The recall includes certain model year 2020- 2025 Jeep Wrangler 4Xe and model year 2022-2026 Grand Cherokee 4Xe plug-in hybrid vehicles.
Via
Stocktwits
Topics
Product Recall
Alibaba’s AI Glasses To Be Priced At $659, Pre-Sale On October 24 On Its E-commerce Platform Tmall: Report
↗
October 23, 2025
According to a CNBC report, the price of the product, known as Quark AI Glasses, during pre-sale would be 4,699 yuan.
Via
Stocktwits
Topics
Artificial Intelligence
AstraZeneca Unveils Expanded Facility In Texas Aimed At Doubling Production Of Hyperkalemia Drug
↗
October 15, 2025
The facility in Coppell, which employs more than 250 people, is the sole global manufacturing facility for the company’s Lokelma.
Via
Stocktwits
US Regulator Closes Probe Into Stellantis’ 24,000 Alfa Romeo Giulia Vehicles
↗
September 29, 2025
Via
Stocktwits
US FDA Alleges Novo Nordisk’s Video On Weight-loss Drugs Featuring Oprah Winfrey Is ‘False Or Misleading’
↗
September 16, 2025
Via
Stocktwits
Novo Nordisk Says New Obesity Treatment Achieved 11.8% Body Weight Reduction In Late-stage Study
↗
September 16, 2025
Via
Stocktwits
< Previous
1
2
3
Next >
